The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin-Reference-Cited by-同舟云学术

The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin

Published:2015-11-23 Issue:6 Volume:55 Page:711-721
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Hibma Jennifer E.,Zur Arik A.,Castro Richard A.,Wittwer Matthias B.,Keizer Ron J.,Yee Sook Wah,Goswami Srijib,Stocker Sophie L.,Zhang Xuexiang,Huang Yong,Brett Claire M.,Savic Radojka M.,Giacomini Kathleen M.

Funder

National Institutes of Health

Swisse National Science Foundation

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40262-015-0346-3.pdf

Reference54 articles.

1. Hillgren KM, Keppler D, Zur AA, Giacomini KM, Stieger B, Cass CE, et al. Emerging transporters of clinical importance: an update from the International Transporter Consortium. Clin Pharmacol Ther. 2013;94:52–63.

2. Lu M, Symersky J, Radchenko M, Koide A, Guo Y, Nie R, et al. Structures of a Na+-coupled, substrate-bound MATE multidrug transporter. Proc Natl Acad Sci. 2013;110:2099–104.

3. Lu M, Radchenko M, Symersky J, Nie R, Guo Y. Structural insights into H+-coupled multidrug extrusion by a MATE transporter. Nat Struct Mol Biol. 2013;20:1310–7.

4. Damme K, Nies AT, Schaeffeler E, Schwab M. Mammalian MATE (SLC47A) transport proteins: impact on efflux of endogenous substrates and xenobiotics. Drug Metab Rev. 2011;43:499–523.

5. Motohashi H, Inui K. Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K. Mol Aspects Med. 2013;34:661–8.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of the circadian timing system on drug metabolism and detoxification: an update;Expert Opinion on Drug Metabolism & Toxicology;2024-05-20

2. Evaluation of OCT2‐mediated drug–drug interactions between ulotaront and metformin in subjects with schizophrenia;Pharmacology Research & Perspectives;2024-03-25

3. Use of a Double-Transfected System to Predict hOCT2/hMATE1-Mediated Renal Drug–Drug Interactions;Drug Metabolism and Disposition;2024-02-07

4. Membrane transporters in drug development and as determinants of precision medicine;Nature Reviews Drug Discovery;2024-01-24

5. Metformin-Cimetidine Drug Interaction and Risk of Lactic Acidosis in Renal Failure: A Pharmacovigilance-Pharmacokinetic Appraisal;Diabetes Care;2023-11-10